EP News Bureau, Author at Express Pharma - Page 4 of 1017

Yugal Sikri outlines 3 key trends defining India’s pharma growth in 2025

Granules Pharmaceuticals gains U.S. FDA approval for Lisdexamfetamine Dimesylate chewable tablets

Schizophrenia market to reach $17 billion in 7MM by 2031, forecasts GlobalData

Unmet needs in chronic hand eczema present clear demand for new treatments: GlobalData

Gerresheimer: FDA grants tentative approval of SQ innovation’s Lasix ONYU

Biocon Biologics’ Ustekinumab Biosimilar receives positive CHMP opinion

Anil Matai reflects on 2024 as a pivotal year for India’s pharma sector

Lupin acquires anti-diabetes trademarks from Boehringer Ingelheim to strengthen portfolio

Glenmark launches Lacosamide Oral Solution, bioequivalent to Vimpat

Rusan Pharma achieves key GMP approvals for Australian and Brazilian markets